enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. BRCA2 - Wikipedia

   en.wikipedia.org/wiki/BRCA2

   In addition to breast cancer in men and women, mutations in BRCA2 also lead to an increased risk of ovarian, uterine tube, prostate and pancreatic cancer. In some studies, mutations in the central part of the gene have been associated with a higher risk of ovarian cancer and a lower risk of prostate cancer than mutations in other parts of the gene.

3. BRCA mutation - Wikipedia

   en.wikipedia.org/wiki/BRCA_mutation

   However, BRCA mutations can increase the risk of other cancers, such as colon cancer, pancreatic cancer, and prostate cancer. Methods to diagnose the likelihood of a patient with mutations in BRCA1 and BRCA2 getting cancer were covered by patents owned or controlled by Myriad Genetics.

4. Prostate cancer shouldn’t be a death sentence. But for a ...

   www.aol.com/finance/prostate-cancer-shouldn-t...

   A young patient with an “aggressive-looking” prostate cancer, whose father had the condition and who carries a BRCA2 mutation, is an entirely different patient from “an 80-year-old man who ...

5. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.

6. Pharma giant Regeneron is spending $119.5M on the world ... - AOL

   www.aol.com/finance/pharma-giant-regeneron...

   For instance, we know that mutations in the genes BRCA1 and BRCA2 are associated with a higher risk of breast and ovarian cancer in women and breast and prostate cancer in men. People can undergo ...

7. Hereditary breast–ovarian cancer syndrome - Wikipedia

   en.wikipedia.org/wiki/Hereditary_breast–ovarian...

   People with BRCA1 and BRCA2 mutations are recommended to have a transvaginal ultrasound 1-2 times per year. Screening with CA-125 is also recommended.. Prophylactic salpingo-oophorectomy (removal of the ovaries and fallopian tubes to prevent cancer) is recommended at age 35-40 for people with BRCA1 mutations and at age 40-45 for people with BRCA2 mutations. [6]